Update on experts’ meeting (advisory board)
13, October, 2017
Posted In: Featured
Recently, at the Admedus advisory board meeting run consecutively with the EACTS annual congress in Vienna, doctors validated the clinical benefits/medical utility and value to patients of our single piece aortic valve (vs. three piece leaflet from the competitors) in both the TAVR and SAVR settings. Our development work in this area continues as we work to build Admedus as a bankable business with an ambitious global strategy.
Experts’ meetings are a platform to engage selected global key opinion leaders to provide companies like Admedus with important feedback and advice on how to develop and bring products to the market. Such events, which are by invitation only, are an accepted and useful mechanism for credible and respected healthcare companies to receive useful feedback and expert validation from the leading doctors in their fields on areas of unmet medical need, clinical relevance, and patient benefit.
Admedus expects to convene many such meetings in the future as we continuously improve our clinically superior ADAPT tissue engineering process and expand our product portfolio to help create life-changing outcomes for patients worldwide.